CBI’s 8th Biosimilars Summit

January 9, 2013 7:13 AM

CBI, a subsidiary of Advanstar Communications Inc. is organizing the “8th  Biosimilars Summit” in Washington, DC., between 5-6 March, 2013.

Here is the brief description of the conference:

“Position Yourself for Commercial Success in the Evolving Biosimilars Landscape – Implications and Applications for Biosimilar and Innovator Companies- The long-awaited FDA guidance on biosimilars has finally been released, but the industry is far from having all of their questions answered. Understanding the regulatory and commercial realities of the biologics market is crucial for educating HCPs and payers to safely introduce biosimilars into the U.S. healthcare system. Our summit places unique focus on the assessment of market access, strategies for effective commercialization and options for interchangeability. Join us to explore the current climate for biosimilars business and evaluate competition, reimbursement strategies and patient safety. 

For more information, please check the link: http://www.cbinet.com/biosimilars

Would you like to post an event on Biosimilar News?

Leave a Reply

Twitter ID
(ID only. No links or "@" symbols)

Latest News on Biosimilar News

Share an Article?

Writing an article is not only a great way to share your knowledge, but it is also a great way to give back to the community.

We value all our contributors and if you have a website, we will surely give a link back to your site and products.
Wanna contribute?


Biosimilar News was started for the people who are interested in this rapidly growing business area. So if you have suggestions or feedback on how we can improve, please let us know. If you want to see a specific topic covered, answer to a specific question, or anything else of this sort, just write us. We do our best to keep up!
Make a suggestion now!